About Hospital General Universitario Gregorio Marañon; Servicio de Hematología
The Hospital General Universitario Gregorio Marañón is a public general hospital located at the neighborhood of Ibiza in Madrid, Spain, part of the hospital network of the Servicio Madrileño de Salud.
There are 1,671 beds in Hospital General Universitario Gregorio Marañon; Servicio de Hematología.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Genentech, Inc.
1
Clinical Trials at Hospital General Universitario Gregorio Marañon; Servicio de Hematología
During the past decade, Hospital General Universitario Gregorio Marañon; Servicio de Hematología conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
2022-03-22
2025-06-01
Recruiting
40
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario Gregorio Marañon; Servicio de Hematología"
#1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hospital General Universitario Gregorio Marañon; Servicio de Hematología
According to Clinical.Site data, the most researched conditions in "Hospital General Universitario Gregorio Marañon; Servicio de Hematología" are
"Leukemia, Lymphocytic, Chronic, B-Cell" (1 trials), "Lymphoma" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Hospital General Universitario Gregorio Marañon; Servicio de Hematología" in a lesser frequency.
Clinical Trials Intervention Types at Hospital General Universitario Gregorio Marañon; Servicio de Hematología
Most popular intervention types in "Hospital General Universitario Gregorio Marañon; Servicio de Hematología" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (2 trials), "Rituximab" (2 trials), "Tocilizumab" (2 trials), "CHOP" (1 trials) and "Cevostamab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital General Universitario Gregorio Marañon; Servicio de Hematología
The vast majority of trials in "Hospital General Universitario Gregorio Marañon; Servicio de Hematología" are
4 trials for "All" genders.
Clinical Trials Status at Hospital General Universitario Gregorio Marañon; Servicio de Hematología
Currently, there are NaN active trials in "Hospital General Universitario Gregorio Marañon; Servicio de Hematología".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hospital General Universitario Gregorio Marañon; Servicio de Hematología,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital General Universitario Gregorio Marañon; Servicio de Hematología, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".